The role of perturbed nitric oxide signalling in disruption of the neurovascular unit of the blood brain barrier by environmental and genetic risk factors for Alzheimer’s disease

Award Number
PG/14/56/30976
Programme
Project Grant
Status / Stage
Completed
Dates
20 November 2014 -
20 November 2017
Duration (calculated)
03 years 00 months
Funder(s)
British Heart Foundation (BHF)
Funding Amount
£274,600.00
Funder/Grant study page
British Heart Foundation
Contracted Centre
Imperial College London
Principal Investigator
Professor James Scott
PI Contact
j.scott@imperial.ac.uk
WHO Catergories
Understanding Underlying Disease
Disease Type
Alzheimer's Disease (AD)

CPEC Review Info
Reference ID592
ResearcherReside Team
Published29/06/2023

Data

Award NumberPG/14/56/30976
Status / StageCompleted
Start Date20141120
End Date20171120
Duration (calculated) 03 years 00 months
Funder/Grant study pageBritish Heart Foundation
Contracted CentreImperial College London
Funding Amount£274,600.00

Plain English Summary

Dr James Scott and colleagues from Imperial College London will investigate how factors that increase the risk of cardiovascular disease also increase the risk of Alzheimer’s disease potentially by damaging the blood brain barrier. The blood brain barrier is a lining of endothelial cells that fit tightly together, forming a barrier between the circulating blood and the brain. It protects the brain from toxins in the blood and maintains a constant brain environment. The blood brain barrier can be injured by heart disease risk factors, and because the brain needs a good blood supply, this injury can also predispose to Alzheimer’s disease. A gas, nitric oxide, which controls blood flow and inflammation, is thought to be involved in keeping the blood brain barrier healthy. In low amounts, nitric oxide protects the brain, but high levels of nitric oxide can harm the brain. In this research project, the group will investigate if the genetic and environmental risk factors that cause cardiovascular disease also damage the blood brain barrier by disrupting normal nitric oxide signalling. They will test if drugs that seal leaks in the blood brain barrier help to prevent damage to the brain. This group’s research will help develop treatments for injuries to the blood brain barrier which may reduce the risk of Alzheimer’s disease.